Title: Restraining the flexibility of the central linker in terameprocol results in constrained analogs with improved growth inhibitory activity.
Journal: Bioorganic & medicinal chemistry letters 20131115
Title: Phase I study of terameprocol in patients with recurrent high-grade glioma.
Journal: Neuro-oncology 20120401
Title: Significant biological role of sp1 transactivation in multiple myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20111015
Title: Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.
Journal: The Journal of pathology 20110301
Title: Terameprocol (tetra-O-methyl nordihydroguaiaretic acid), an inhibitor of Sp1-mediated survivin transcription, induces radiosensitization in non-small cell lung carcinoma.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110101
Title: Glycosylated nordihydroguaiaretic acids as anti-cancer agents.
Journal: Bioorganic & medicinal chemistry letters 20110101
Title: Inhibition of poxvirus growth by Terameprocol, a methylated derivative of nordihydroguaiaretic acid.
Journal: Antiviral research 20101201
Title: Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid.
Journal: Bioorganic & medicinal chemistry letters 20090815
Title: Lignans with anti-HIV activity from Schisandra propinqua var. sinensis.
Journal: Journal of natural products 20090601
Title: Phase I clinical trial of repeat dose terameprocol vaginal ointment in healthy female volunteers.
Journal: Sexually transmitted diseases 20080601
Title: New nordihydroguaiaretic acid derivatives as anti-HIV agents.
Journal: Bioorganic & medicinal chemistry letters 20080315
Title: Terameprocol, a novel site-specific transcription inhibitor with anticancer activity.
Journal: IDrugs : the investigational drugs journal 20080301
Title: Phase I/II clinical safety studies of terameprocol vaginal ointment.
Journal: Gynecologic oncology 20071201
Title: The anticancer activity of the transcription inhibitor terameprocol (meso-tetra-O-methyl nordihydroguaiaretic acid) formulated for systemic administration.
Journal: Anti-cancer drugs 20070901
Title: Survivin-dependent and -independent pathways and the induction of cancer cell death by tetra-O-methyl nordihydroguaiaretic acid.
Journal: Seminars in oncology 20060801
Title: Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20050615
Title: CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target.
Journal: The American journal of surgical pathology 20050301
Title: Structure-activity relationship studies of nordihydroguaiaretic acid inhibitors toward soybean, 12-human, and 15-human lipoxygenase.
Journal: Journal of medicinal chemistry 20020606
Title: tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo.
Journal: Cancer letters 20010928
Title: Johns Hopkins embroiled in fresh misconduct allegations.
Journal: Nature 20010802
Title: Tetra-O-methyl nordihydroguaiaretic acid induces G2 arrest in mammalian cells and exhibits tumoricidal activity in vivo.
Journal: Cancer research 20010715
Title: Antiviral activities of methylated nordihydroguaiaretic acids. 1. Synthesis, structure identification, and inhibition of tat-regulated HIV transactivation.
Journal: Journal of medicinal chemistry 19980730
Title: Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Journal: Journal of medicinal chemistry 19980730
